Arbutus Announces 2024 Corporate Objectives and Provides Financial Update

January 8, 2024

https://www.globenewswire.com/news-release/2024/01/08/2805327/14025/en/Arbutus-Announces-2024-Corporate-Objectives-and-Provides-Financial-Update.html

Additional data from two on-going Phase 2a clinical trials evaluating imdusiran, our RNAi therapeutic, as a cornerstone therapy in combination with other compounds expected in 2024

Read more at globenewswire.com

Related news for (ABUS)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.